Means Investment Co., Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Means Investment Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $216,675 - $307,762	-3,730 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$61.35 - $90.47 $6,135 - $9,047	-100 Reduced 2.61%	3,730 $247,000
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $19,719 - $38,416	-450 Reduced 10.51%	3,830 $338,000
Q3 2020 Nov 09, 2020	BUY	$33.21 - $51.27 $142,138 - $219,435	4,280 New	4,280 $284,000
Q1 2020 Apr 23, 2020	SELL	$20.56 - $63.12 $87,277 - $267,944	-4,245 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$28.14 - $73.01 $119,454 - $309,927	4,245 New	4,245 $240,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Means Investment Co., Inc. with notifications on news.